Research guide · Recovery & Repair
Oxytocin — research protocol
Oxytocin — 9-amino-acid neuropeptide synthesized in the hypothalamus and released by the posterior pituitary. Studied for social bonding, trust, empathy, stress buffering, and modulation of the HPA axis in preclinical and clinical research.
This guide summarizes study areas and sources associated with the compound. BioPeptideX does not convert experimental information into a clinical regimen or recommend an individual dose, frequency, route or duration.
Catalog presentations
Concentration table
Mathematical reference only; this is not a dosing recommendation.
Research areas
- Endogenous nonapeptide — the 'bonding hormone'
- Studied for social connection, trust and empathy research
- Buffers cortisol and stress reactivity via HPA-axis modulation
- Investigated for anxiety, PTSD and mood research models
- Rapid onset in reported studies — minutes
- Lyophilized powder, 99% HPLC verified purity — COA included
Most-cited research protocols
Educational information based on research protocols and literature; it does not replace guidance from a healthcare professional.
Oxytocin, a peptide hormone, is studied for its effects on stress, social behavior, and mood when administered intranasally or subcutaneously, routes not approved by the FDA. This page serves as a research reference, distinguishing approved uses from investigational ones and detailing dosing protocols.
| Dose | Frequency | Duration | Route | |
|---|---|---|---|---|
| Intranasal Single-dose social-cognition studies | 24 IU | 1x | 1 session | Intranasal |
| Intranasal Dose-response brain imaging | 9, 18, or 36 IU | 1x | 1 session | Intranasal |
| Intranasal SOARS-B autism RCT | Up to 48 IU/day total | Split twice daily | 24 weeks | Intranasal |
| Subcutaneous Low | 100 mcg | Once daily | Not specified | Subcutaneous |
Cycle: Standard cycle duration is 4-6 weeks, often followed by a 1-2 week off period.
Benefits and research observations: Acute social-cognition effects are often measured within 30-90 minutes post-dose. Longer-term symptom endpoints may be tracked over 12-24 weeks of treatment.
Handling and storage
Store unreconstituted product according to its label and maintain the cold chain where applicable. After any preparation, follow only validated instructions for the specific product and diluent. Do not use if packaging is damaged or the solution shows particles or unexpected changes.
Warnings
Do not use this page for self-diagnosis or self-medication. Pregnancy, breastfeeding, minors, cancer history, allergies, active disease and concurrent treatments require individual professional evaluation.
Published sources
- 1.Insel TR, Young LJ. Nat Rev Neurosci, 2001.
- 2.Kosfeld M, et al. Nature, 2005.
- 3.Heinrichs M, et al. Front Neuroendocrinol, 2009.